NetWorth
LeaderPortfolio
Kong
Lam Kong
Rank #1859
CHINA•Healthcare•Pharmaceuticals

Lam Kong

Net Worth
$2.203B
+3.55% (24h)
Lam Kong is a Hong Kong-based billionaire with a net worth of $2.7 billion as of 2024. His wealth stems from his leadership of China Medical System (CMS), a leading pharmaceutical company in China. His career began with a small pharmaceutical trading business, which he transformed into a major player in the industry. Lam is recognized for his strong leadership and clinical background, which he leverages to implement successful development strategies. His work has contributed to the company's listing on the Hong Kong Stock Exchange and the distribution of essential medications. Lam received a bachelor's degree from Guangdong Medical College. He is currently 61 years old and resides in Hong Kong.

How to read Lam Kong's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Lam Kong, we anchor the narrative to Pharmaceuticals and Pharmaceuticals, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $2.203B alongside global rank #1859, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (CHINA) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life and Education

Lam Kong's journey began with a foundation in clinical medicine, earning a bachelor's degree from Zhanjiang Medical College in 1986, now known as Guangdong Medical University. This educational background provided him with a deep understanding of the pharmaceutical industry, which would later prove invaluable.

Rise to Success

Lam's career started with a small business in pharmaceutical product trading. Over ten years, he successfully grew this venture into a multi-billion dollar enterprise. In 1995, he founded China Medical System (CMS), serving as its Chairman and Chief Executive Officer. Under his leadership, CMS has become a major distributor of both imported and locally produced pharmaceuticals and has been listed on the Hong Kong Stock Exchange. Lam's experience includes over 16 years in the marketing, promotion, and sales of pharmaceutical products.

Key Business Strategies

Lam is responsible for the creation, implementation, and management of CMS's development and growth strategies. His efforts have significantly contributed to the company's success in the distribution of drugs, including anti-depressants and liver ailment medications, to numerous hospitals in China. CMS also engages in the manufacturing and import of prescription drugs. The company's focus is on producing excellent products for physicians, patients, and pharmaceutical manufacturers through professional promotion services.

Achievements and Awards

Lam Kong is also a co-inventor of a drug called CMS024, used for the treatment of primary liver carcinoma. Under his leadership, China Medical Systems has garnered numerous awards and honors. The company was included in the list of “Asia's Best Enterprise under a billion” in 2008, 2010, 2011, 2012 and 2014. Lam was also included in the 2014 Shenzhen Major Project Plan.

Career Timeline

2010

China Medical System went public

The company was listed on the Hong Kong Stock Exchange.

1995

Founded China Medical System (CMS)

Established the company, serving as Chairman and CEO, and leading its growth into a major pharmaceutical distributor.

1986

Graduated from Zhanjiang Medical College

Obtained a bachelor's degree in clinical medicine, laying the foundation for his future in the pharmaceutical industry.

Key Business Ventures & Holdings

CompanyStakeValue
China Medical System Holdings Ltd—$17.8M

Net Worth History

In-Depth Analysis

Early Life and Education

Lam Kong's journey began with a foundation in clinical medicine, earning a bachelor's degree from Zhanjiang Medical College in 1986, now known as Guangdong Medical University. This educational background provided him with a deep understanding of the pharmaceutical industry, which would later prove invaluable.

Rise to Success

Lam's career started with a small business in pharmaceutical product trading. Over ten years, he successfully grew this venture into a multi-billion dollar enterprise. In 1995, he founded China Medical System (CMS), serving as its Chairman and Chief Executive Officer. Under his leadership, CMS has become a major distributor of both imported and locally produced pharmaceuticals and has been listed on the Hong Kong Stock Exchange. Lam's experience includes over 16 years in the marketing, promotion, and sales of pharmaceutical products.

Key Business Strategies

Lam is responsible for the creation, implementation, and management of CMS's development and growth strategies. His efforts have significantly contributed to the company's success in the distribution of drugs, including anti-depressants and liver ailment medications, to numerous hospitals in China. CMS also engages in the manufacturing and import of prescription drugs. The company's focus is on producing excellent products for physicians, patients, and pharmaceutical manufacturers through professional promotion services.

Achievements and Awards

Lam Kong is also a co-inventor of a drug called CMS024, used for the treatment of primary liver carcinoma. Under his leadership, China Medical Systems has garnered numerous awards and honors. The company was included in the list of “Asia's Best Enterprise under a billion” in 2008, 2010, 2011, 2012 and 2014. Lam was also included in the 2014 Shenzhen Major Project Plan.

Data Sources & Methodology

Figures for Lam Kong are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.

You may also like

HubAll BillionairesHubGlobal RankingsHubNewsroom